Impaired platelet procoagulant mechanisms in patients with bleeding disorders

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 2, 2009, Pages 233-241

  Weiss, Harvey J ^a,b,c  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Phosphatidylserine (PS); Platelet factor 3 availability (PF3a); Platelet factor V New York; Procoagulant activity (PCA); Prothrombinase; Quebec platelet disorder (QPD); Scott syndrome

Indexed keywords

ADENINE NUCLEOTIDE; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; CALCIUM; FIBRIN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; PHOSPHATIDYLSERINE; PROCOAGULANT; PURINERGIC P2 RECEPTOR; THROMBIN; THROMBOCYTE FACTOR 3; THROMBOCYTE FACTOR 5; UROKINASE; VON WILLEBRAND FACTOR;

BERNARD SOULIER DISEASE; BLEEDING DISORDER; CALCIUM CELL LEVEL; DELTA STORAGE POOL DEFICIENCY; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; NONHUMAN; PLATELET FACTOR V DEFECT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTHROMBIN TIME; QUEBEC PLATELET DISORDER; REVIEW; SCOTT SYNDROME; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; ADULT; AGED; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; CASE REPORT; FEMALE; PATHOLOGY; THROMBOCYTE;

ADULT; AGED; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; FEMALE; HUMANS;

EID: 69249235449     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1220331     Document Type: Review

References (60)

1. Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002;88:186-194
2. Monroe DM, Hoffman M, Roberts H. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381-1389
3. Walsh PN. Platelet-coagulation protein interactions. Semin Thromb Hemost 2004;30:461-471
4. Parise LV, Smyth SS, Shet AS, Coller BS. Platelet morphology, biochemistry, and function. In: Lichtman MA, Kipps TJ, Kaushansky K, Beutler E, Seligsohn U, Prchal JT, eds. Williams Hematology. 7th ed. New York, NY: McGraw-Hill; 2006:1587-1663
5. Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999;19:2841-2846
6. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004;1636:119-128 (Pubitemid 38780788)
7. 2+-ATPase inhibitors. Biochemistry 1995;34:11625-11634
8. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 2001;86:266-275
9. Lages B, Weiss HJ. Secreted dense granule adenine nucleotides promote calcium influx and the maintenance of elevated cytosolic calcium levels in stimulated human platelets. Thromb Haemost 1999;81:286-292 (Pubitemid 29078319)
10. 2+ entry in stimulated cells. Biochem Biophys Res Commun 2000;279:639-645
11. Martinez MC, Martin S, Toti F, et al. Significance of capacitative Ca2+ entry to the regulation of phoshatidylserine expression at the surface of stimulated cells. Biochemistry 1999;38:10092-10098 (Pubitemid 129516498)
12. 2+ entry in the regulation of phoshatidylserine exposure in blood cells from Scott patients. Thromb Haemost 2003;89:687-695
13. Sage SO. Calcium entry mechanisms in human platelets. Exp Physiol 1997;82:807-823
14. Mahaut-Smith MP, Ennion SJ, Rolf MG, Evans RJ. ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 2000;131:108-114
15. 1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors. Br J Pharmacol 2002;135:363-372
16. 2+ in the human platelet. J Thromb Haemost 2007;5:910-917
17. Weiss HJ. Platelet aggregation, adhesion and ADP release in thrombopathia (platelet factor 3 deficiency) - a comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med 1967;43:570-578
18. Owen CA Jr, Thompson JH Jr. Soybean phosphatides in prothrombin consumption and thromboplastin-generation tests: their use in recognizing "thrombasthenic hemophilia". Am J Clin Pathol 1960;33:197-208
19. Weiss HJ, Vicic WJ, Lages BA, Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med 1979;67:206-213 (Pubitemid 9239513)
20. Weiss HJ, Turitto VT, Baumgartner HR. The role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium: studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest 1986;78:1072-1082
21. Weiss HJ. Scott syndrome: a disorder of platelet coagulant activity (PCA). Sem Hematol 1994;31:312-319
22. Miletich JP, Kane WH, Hofmann SL, Stanford N, Majerus PW. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood 1979;54:1015-1022
23. Rosing J, Bevers EM, Comfurius P, et al. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 1985;65:1557-1561 (Pubitemid 15057969)
24. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989;264:17049-17057 (Pubitemid 19255533)
25. Ahmad SS, Rawala-Sheikh R, Ashby B, Walsh PN. Platelet receptor-mediated factor X activation by factor IXa: high affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. J Clin Invest 1989;84:824-828 (Pubitemid 19228353)
26. 2+ induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 1992;79:380-388
27. Kojima H, Newton-Nash D, Weiss HJ, Sims PJ, Zhao J, Wiedmer T. Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 1994;94:2237-2244 (Pubitemid 24379594)
28. 2+-dependent transbilayer migration of membrane phospholipids. J Clin Invest 1997;99:2232-2238
29. Zhou Q, Sims PJ, Wiedmer T. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome. Blood 1998;92:1707-1712 (Pubitemid 28406875)
30. Dekkers DW, Comfurius P, Vuist WMJ, et al. Impaired Ca2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome. Blood 1998;91:2133-2138 (Pubitemid 28185518)
31. Weiss HJ, Lages B. Family studies in Scott syndrome. Blood 1997;90:475-476
32. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phoshatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996;87:1409-1415 (Pubitemid 26056904)
33. 2+- induced activation of platelets from a patient with Scott syndrome. Br J Haematol 1998;101:50-58
34. Janel N, Leroy C, Laude I, et al. Assessment of the expression of candidate human plasma membrane phospholipid scramblase in Scott syndrome cells. Thromb Haemost 1999;81:322-323 (Pubitemid 29078330)
35. 2+ entry. Biochem Biophys Res Commun 2005;327:335-341
36. Kozian D, Proulle V, Nitsche A, et al. Identification of genes involved in Ca2+ ionophore A23187-mediated apoptosis and demonstration of a high susceptibility for transcriptional repression of cell cycle genes in B lymphoblasts from a patient with Scott syndrome. BMC Genomics 2005;6:146 (Pubitemid 41631206)
37. Parry DH, Giddings JC, Bloom AL. Familial haemostatic defect with reduced prothrombin consumption. Br J Haematol 1980;44:323-334
38. 2+ in Scott syndrome. Thromb Haemost 2004;91:412-415
39. Albrecht C, McVey JH, Elliott JI, et al. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood 2005;106:542-549 (Pubitemid 40981249)
40. Brooks MB, Catalfamo JL, Brown HA, Ivanova P, Lovaglio J. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood 2002;99:2434-2441 (Pubitemid 34525429)
41. Brooks MB, Catalfamo JL, Etter K, Brisbin A, Bustamante CD. Exclusion of ABCA-1 as a candidate gene for canine Scott syndrome. J Thromb Haemost 2008;6:1608-1610
42. Castaman G, Yu-Feng L, Battistin E, Rodeghiero F. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997;96:458-463 (Pubitemid 27087227)
43. Weiss HJ, Lages B, Zheng S, Hayward C. Platelet factor V New York - a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. Am J Hematol 2001;66:130-139 (Pubitemid 32096628)
44. Miletich JP, Majerus DW, Majerus PW. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets. J Clin Invest 1978;62:824-831
45. Tracy PB, Giles AR, Mann KG, et al. Quebec: a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984;74:1221-1228
46. Hayward CP, Rivard GE, Kane WH, et al. An autosomal dominant, qualiative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen, and an epinephrine aggregation defect. Blood 1996;87:4967-4978 (Pubitemid 26189838)
47. Janeway CM, Rivard GE, Tracy PB, Mann KG, Factor V. Quebec revisited. Blood 1996;87:3571-3578
48. Diamandis M, Veljkovic DK, Maurer-Spure E, Rivard GE, Hayward CPM. Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagul Fibrinolysis 2008;19: 109-119 (Pubitemid 351252988)
49. Kahr WH, Zheng S, Sheth PM, et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen actvator. Blood 2001;98:257-265
50. Veljkovic DK, Rivard GE, Diamandis M, Blavignac J, Cramer-Bordé EM, Hayward CPM. Increased expression of urokinase plasminogen actvator in Quebec platelet disorder is linked to megakaryocyte differentiation. Blood 2009;113:1535-1542
51. Diamandis M, Paterson AD, Rommens JM, et al. Quebec platelet disorder is linked to the urokinase plasminogen actvator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Blood 2009;113:1543-1546
52. Weiss HJ, Lages B. Platelet prothrombinase activity and intracellular calcium responses in patients with glycoprotein IIb-IIIa deficiency, granule defects, or impaired platelet coagulant activity - a comparison with Scott syndrome. Blood 1997;89:1599-1611 (Pubitemid 27097453)
53. Coller BS, Mitchell WB, French D. Hereditary qualitative platelet disorders. In: Lichtman MA, Kipps TJ, Kaushansky K, et al, eds. Williams Hematology. 7th ed. New York, NY: McGraw-Hill; 2006:1795-1831
54. Reverter JC, Béguin S, Kesseks H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. J Clin Invest 1996;98:863-874
55. Bevers EM, Comfurius P, Nieuwenhuis HK, et al. Platelet prothrombin converting activity in hereditary disorders of platelet function. Br J Haematol 1986;63:335-345 (Pubitemid 16085867)
56. Dormann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000;96:2469-2478
57. Loscalzo J, Inbal A, Handin RI. Von Willebrand protein facilitates platelet incorporation in polymerizing fibrin. J Clin Invest 1986;78:1112-1119 (Pubitemid 17177096)
58. Béguin S, Kumar R, Keularts I, Seligsohn U, Coller BS, Hemker HC. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999;93:564-570 (Pubitemid 29035737)
59. Béguin S, Keularts I, Al Dieri R, Bellucci S, Caen J, Hemker HC. Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome. J Thromb Haemost 2004;2:170-176 (Pubitemid 40185634)
60. Abrams CS, Shattil S, Bennett JS. Acquired qualitative platelet disorders. In: Lichtman MA, Kipps TJ, Kaushansky K, et al, eds. Williams Hematology. 7th ed. New York, NY: McGraw-Hill; 2006:1833-1855